MT Newswires
Wedbush Raises Price Target on Ovid Therapeutics to $7 From $5, Keeps Outperform Rating
📊
AI Sentiment
Positive
7/10
Ovid Therapeutics Inc. News
Latest updates and market news for OVID
8 news
Mar 18 - Mar 24, 2026
Page 1
Motley Fool
Here's Why Ovid Therapeutics Stock Popped Higher Today
📈
AI Sentiment
Highly Positive
9/10
MT Newswires
Exchange-Traded Funds, Equity Futures Lower Ahead of Key Economic Data, FOMC Meeting
âž–
AI Sentiment
Neutral
5/10
MT Newswires
Sector Update: Health Care Stocks Decline Premarket Wednesday
📉
AI Sentiment
Negative
3/10
MT Newswires
Sector Update: Health Care
Share this news page